Susquehanna International Group
ORIC icon

Susquehanna International Group’s Oric Pharmaceuticals ORIC Stock Holding History

Susquehanna International Group’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$292K Buy
+23,055
New +$262K ﹤0.01% 10916
2025
Q4 		– Sell
-16,348
Closed -$188K – 13240
2025
Q3 		$196K Sell
16,348
-124,652
-88% -$1.31M ﹤0.01% 11011
2025
Q2 		$1.43M Buy
141,000
+14,319
+11% +$96.1K ﹤0.01% 6569
2025
Q1 		$707K Buy
126,681
+95,619
+308% +$836K ﹤0.01% 8119
2024
Q4 		$251K Buy
31,062
+5,527
+22% +$50.7K ﹤0.01% 10207
2024
Q3 		$262K Sell
25,535
-8,510
-25% -$84.1K ﹤0.01% 9898
2024
Q2 		$241K Buy
+34,045
New +$305K ﹤0.01% 9948
2024
Q1 		– Sell
-54,389
Closed -$646K – 13014
2023
Q4 		$500K Buy
54,389
+44,300
+439% +$320K ﹤0.01% 8665
2023
Q3 		$61K Sell
10,089
-887
-8% -$7.27K ﹤0.01% 11204
2023
Q2 		$85.2K Sell
10,976
-227,462
-95% -$1.29M ﹤0.01% 11064
2023
Q1 		$1.36M Buy
238,438
+139,151
+140% +$727K ﹤0.01% 6041
2022
Q4 		$585K Buy
99,287
+79,310
+397% +$268K ﹤0.01% 7439
2022
Q3 		$64K Sell
19,977
-60,628
-75% -$243K ﹤0.01% 12045
2022
Q2 		$361K Buy
80,605
+48,533
+151% +$194K ﹤0.01% 9052
2022
Q1 		$171K Buy
32,072
+6,090
+23% +$54.8K ﹤0.01% 11425
2021
Q4 		$382K Buy
25,982
+8,916
+52% +$139K ﹤0.01% 9899
2021
Q3 		$357K Sell
17,066
-4,978
-23% -$101K ﹤0.01% 10200
2021
Q2 		$390K Sell
22,044
-21,312
-49% -$467K ﹤0.01% 10199
2021
Q1 		$1.06M Buy
+43,356
New +$1.37M ﹤0.01% 7581

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Susquehanna International Group's ORIC Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 23,055 shares worth $292K. The stake represents ﹤0.01% of the portfolio and ranks #10916 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in ORIC as recently as Q3 2025.

Susquehanna International Group first reported a position in ORIC in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.43M in Q2 2025. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Susquehanna International Group held 23,055 shares of Oric Pharmaceuticals worth $292K as of Q1 2026.
  • Oric Pharmaceuticals was a new Susquehanna International Group position in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10916 holding.
  • Susquehanna International Group first reported a position in Oric Pharmaceuticals in Q1 2021 and has held it in 19 quarters since.
  • Susquehanna International Group's Oric Pharmaceuticals position peaked at $1.43M in Q2 2025.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.